Catherine Wu, M.D.
Catherine J. Wu is an associated researcher and institute member in the Broad Institute’s Cancer Program. She is an associate professor of medicine at Harvard Medical School and Dana-Farber Cancer Institute (DFCI), as well as a staff physician at DFCI and Brigham and Women’s Hospital.
Wu’s research is primarily focused on chronic lymphocytic leukemia (CLL). Her lab is using cutting edge genomic technologies to understand the underlying biology of the disease and to develop effective therapies. This includes using next-generation, massively parallel sequencing technologies to identify and assess the potential functional effects of genetic mutations found within CLL cells. This information is used to identify novel, tumor-specific targets for immune-based treatment, and to develop a thorough understanding of the mutational landscape of CLL.
Wu graduated from Harvard University with a degree in biochemistry, and earned her medical degree from Stanford University School of Medicine. She spent her residency in internal medicine at Brigham and Women’s Hospital and completed a postdoctoral fellowship in hematology-oncology at the DFCI/Partners CancerCare training program. She is a member of the American Society of Clinical Investigation, a recipient of a 2011 Stand-Up to Cancer Innovative Research Grant from the American Association for Cancer Research, and a scholar of the Leukemia and Lymphoma Society.